CRMD vs FDMT โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
CRMD Captures Institutional Edge (2โ2 Pillars ยท 6โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to CorMedix Inc. (CRMD) driven by superior Valuation, Growth & Margin while FDMT counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, CRMD trades at 29.5x Forward P/E with 41.0% operating margin (-47.7% YoY revenue) versus FDMT at N/M Forward P/E and -222.7% operating margin (+4505.6% YoY). In options structure, CRMD sits in BREAKDOWN (22nd %ile IV; Dealer Gamma Walls on Pro) against FDMT sits in BREAKDOWN (10th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | CRMD Revenue | FDMT Revenue | CRMD Op. Margin | FDMT Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $0M | N/A | -6250.4% | N/A | CRMD |
| FY2019 | $0M | $10M | -7416.3% | -729.4% | FDMT |
| FY2020 | $0M | $10M | -11378.4% | -424.0% | FDMT |
| FY2021 | $0M | $20M | -15417.5% | -395.5% | FDMT |
| FY2022 | $0M | $0M | -46819.9% | -3516.5% | FDMT |
| FY2023 | N/A | $20M | N/A | -544.6% | FDMT |
| FY2024 | $40M | $0M | -51.4% | -507678.4% | CRMD |
| FY2025 | $310M | $90M | 48.2% | -187.2% | CRMD |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | CRMD | FDMT | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $370.6M | $689.5M | Larger Scale | FDMT |
| Trailing P/E Ratio Valuation | 2.4x | N/M | Lower Multiple | CRMD |
| Forward P/E Ratio Valuation | 29.5x | N/M | Lower Multiple | CRMD |
| Revenue Growth (YoY) Growth | -47.7% | +4505.6% | Higher Growth | FDMT |
| Operating Margin (TTM) Profitability | 41.0% | -222.7% | Higher Margin | CRMD |
| Net Profit Margin Profitability | 15.5% | -208.6% | Higher Margin | CRMD |
| Return on Equity (ROE) Capital Efficiency | 15.3% | -56.7% | Higher ROE | CRMD |
| 52-Week Range Position Momentum | 1% ($5โ$13) | 38% ($7โ$17) | Stronger Trend | FDMT |
| Beta / 30D Volatility Risk Regime | 1.22ฮฒ ยท 103% Vol | 1.96ฮฒ ยท 93% Vol | Lower Realized Risk | FDMT |
| Unified Institutional Score Composite Signal | 55.5 / 100 (HOLD) | 41.5 / 100 (SELL) | Higher Composite | CRMD |